YONGHE MED.GR.DL-0000025 (L97) - Net Assets
Based on the latest financial reports, YONGHE MED.GR.DL-0000025 (L97) has net assets worth €787.37 Million EUR (≈ $920.52 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.70 Billion ≈ $1.99 Billion USD) and total liabilities (€914.47 Million ≈ $1.07 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore balance sheet size of YONGHE MED.GR.DL-0000025 for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €787.37 Million |
| % of Total Assets | 46.27% |
| Annual Growth Rate | -17.48% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 19.03 |
YONGHE MED.GR.DL-0000025 - Net Assets Trend (2021–2025)
This chart illustrates how YONGHE MED.GR.DL-0000025's net assets have evolved over time, based on quarterly financial data. Check YONGHE MED.GR.DL-0000025 tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for YONGHE MED.GR.DL-0000025 (2021–2025)
The table below shows the annual net assets of YONGHE MED.GR.DL-0000025 from 2021 to 2025. For live valuation and market cap data, see YONGHE MED.GR.DL-0000025 (L97) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €787.37 Million ≈ $920.52 Million |
+10.31% |
| 2024-12-31 | €713.80 Million ≈ $834.51 Million |
-24.24% |
| 2023-12-31 | €942.25 Million ≈ $1.10 Billion |
-40.56% |
| 2022-12-31 | €1.59 Billion ≈ $1.85 Billion |
-6.66% |
| 2021-12-31 | €1.70 Billion ≈ $1.99 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to YONGHE MED.GR.DL-0000025's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 272.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €1.31 Billion | 166.30% |
| Total Equity | €788.05 Million | 100.00% |
YONGHE MED.GR.DL-0000025 Competitors by Market Cap
The table below lists competitors of YONGHE MED.GR.DL-0000025 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aemetis Inc
NASDAQ:AMTX
|
$109.07 Million |
|
Nien Hsing Textile Co Ltd
TW:1451
|
$109.17 Million |
|
Han Chang Pape
KO:009460
|
$109.18 Million |
|
Bank Qnb Indonesia Tbk
JK:BKSW
|
$109.19 Million |
|
Leadtrend Technology Corp
TW:3588
|
$108.98 Million |
|
Coda Octopus Group Inc
NASDAQ:CODA
|
$108.97 Million |
|
Shin Foong Specialty and Applied Materials Co
TW:6582
|
$108.88 Million |
|
Hod Assaf Industries Ltd
TA:HOD
|
$108.87 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in YONGHE MED.GR.DL-0000025's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 714,337,000 to 788,055,000, a change of 73,718,000 (10.3%).
- Net income of 73,711,000 contributed positively to equity growth.
- Share repurchases of 87,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €73.71 Million | +9.35% |
| Share Repurchases | €87.00K | -0.01% |
| Other Changes | €94.00K | +0.01% |
| Total Change | €- | 10.32% |
Book Value vs Market Value Analysis
This analysis compares YONGHE MED.GR.DL-0000025's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.14x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €3.27 | €0.22 | x |
| 2022-12-31 | €3.01 | €0.22 | x |
| 2023-12-31 | €1.88 | €0.22 | x |
| 2024-12-31 | €1.43 | €0.22 | x |
| 2025-12-31 | €1.58 | €0.22 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently YONGHE MED.GR.DL-0000025 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.35%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.08%
- • Asset Turnover: 1.06x
- • Equity Multiplier: 2.16x
- Recent ROE (9.35%) is above the historical average (-15.73%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 7.08% | 5.54% | 0.68x | 1.88x | €-49.65 Million |
| 2022 | -5.42% | -6.08% | 0.48x | 1.85x | €-244.39 Million |
| 2023 | -57.97% | -30.74% | 0.73x | 2.59x | €-640.65 Million |
| 2024 | -31.69% | -12.54% | 1.05x | 2.42x | €-297.78 Million |
| 2025 | 9.35% | 4.08% | 1.06x | 2.16x | €-5.09 Million |
Industry Comparison
This section compares YONGHE MED.GR.DL-0000025's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $4,122,663,549
- Average return on equity (ROE) among peers: -20.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| YONGHE MED.GR.DL-0000025 (L97) | €787.37 Million | 7.08% | 1.16x | $109.02 Million |
| China Resources Medical Holdings Company Limited (1PH) | $5.60 Billion | 7.52% | 0.23x | $413.92 Million |
| AEST.MED.INT.HLD.SP.ADR/3 (3FMA) | $9.35 Million | -213.41% | 51.02x | $3.30 Million |
| JINXIN FERT.GRP HD-00001 (3NX) | $8.75 Billion | 3.88% | 0.47x | $656.44 Million |
| REVITALIST L.A.W. LTD (4DO) | $-11.05 Million | 0.00% | 0.00x | $744.60K |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.33 Billion | -1.83% | 0.99x | $15.67 Million |
| HYGEIA HC HLDGS DL-00001 (50I) | $4.48 Billion | 9.86% | 0.49x | $12.24K |
| COMPASS PATHW SP.ADR (5Y6) | $284.41 Million | -25.22% | 0.06x | $657.30 Million |
| Bumrungrad Hospital Public Company Limited (BZ7A) | $18.74 Billion | 22.15% | 0.32x | $54.39K |
| Eifelhöhen-Klinik AG (EIF) | $14.93 Million | -9.50% | 3.71x | $10.05 Million |
| Fresenius Medical Care AG & Co. KGaA (FME) | $2.03 Billion | 0.80% | 1.39x | $10.01 Billion |
About YONGHE MED.GR.DL-0000025
Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China. The company offers hair transplant, medical hair care, routine hair restoration, and other ancillary services. It also engages provision of hair research and consulting services; investment and management; and wig business. The company was founded in 2005 and is headquartered in Beijing, China.